72% of Florida Business Leaders Say Biotech is Florida's Next Innovation Boom, According to Foley Flash Poll
05 May 2008
Despite Importance of Intellectual Property in Biotech Growth, One in Three Still Classify Their IP Strategy as “Defensive/Reactive”
A flash poll of business leaders at a recent Foley conference revealed insights into where the state is likely headed in terms of business growth – with 72 percent indicating that biotech will see the most significant growth in the next two years. However, despite the role a strong Intellectual Property (IP) strategy will play in the growth of these areas, 36 percent of respondents characterized their company’s approach to IP as “defensive/reactive.”
Click here to download the press release
Related Insights
20 January 2025
PharmaPatents
Federal Circuit Says Proper Orange Book-Listed Patent Must Claim Active Ingredient
In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon of scrutinizing the types of patents that can be listed in the Food & Drug Administration (FDA) Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations), and decided that the “device” patents at issue were not properly listable.
17 January 2025
Foley Career Perspectives
Strive Without Strife: Your Guide to 2025
The start of a new year often inspires lofty resolutions, if not illusions of grandeur, about the habits we’ll develop and professional goals we’ll conquer: more billable hours, bigger matters, rapid career advancement, and the like.
17 January 2025
Consumer Class Defense Counsel
FTC Announces Final Junk Fees Rule Applying to Live-Event Tickets and Short-Term Lodging
On December 17, 2024, the U.S. Federal Trade Commission announced its final “Junk Fees Rule” to prevent certain practices related to pricing in the live-event ticketing and short-term lodging industries.